Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

INTRODUCTION: Curcumin is a polyphenolic compound derived from the plant Curcuma Long Lin that has been demonstrated to have antioxidant and anti-inflammatory effects as well as effects on reducing beta-amyloid aggregation. It reduces pathology in transgenic models of Alzheimer's disease (AD) a...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Ringman, John M, Frautschy, Sally A, Teng, Edmond, Begum, Aynun N, Bardens, Jenny, Beigi, Maryam, Gylys, Karen H, Badmaev, Vladimir, Heath, Dennis D, Apostolova, Liana G, Porter, Verna, Vanek, Zeba, Marshall, Gad A, Hellemann, Gerhard, Sugar, Catherine, Masterman, Donna L, Montine, Thomas J, Cummings, Jeffrey L, Cole, Greg M
Format: Artigo
Język:Inglês
Wydane: BioMed Central 2012
Hasła przedmiotowe:
Research
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3580400/
https://ncbi.nlm.nih.gov/pubmed/23107780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt146
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy